# Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/five-year-follow-up-of-nivolumab-in-previously-treated-advanced-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Scott Gettinger,Leora Horn,David M. Jackman,David R. Spigel,Scott Antonia,Matthew D. Hellmann,John D. Powderly,Rebecca S. Heist,Lecia V. Sequist,David C. Smith,Philip D. Leming,William J. Geese,Dennis J. Yoon,Ang Li,Julie R. Brahmer |
| Citations | 750 |
| DOI | 10.1200/jco.2017.77.0412 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2791043965 |
| PMID | 29570421 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [Rebecca S. Heist](https://scholariq.org/researchers/rebecca-s-heist/)
- [Lecia V. Sequist](https://scholariq.org/researchers/lecia-v-sequist/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.